Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group.
Jeger RV, Eccleshall S, Wan Ahmad WA, Ge J, Poerner TC, Shin ES, Alfonso F, Latib A, Ong PJ, Rissanen TT, Saucedo J, Scheller B, Kleber FX; International DCB Consensus Group.
JACC Cardiovasc Interv. 2020 Jun 22;13(12):1391-1402. doi: 10.1016/j.jcin.2020.02.043. Epub 2020 May 27.
Angioplasty with drug-coated balloon catheters: the coming tide?
Byrne RA, Durand R.
EuroIntervention. 2024 Jul 1;20(13):e786-e788. doi: 10.4244/EIJ-E-24-00035.
Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives.
Lunardi M, Zivelonghi C, van den Brink FS, Ghione M, Vinco G, Benfari G, Scarsini R, Ribichini F, Agostoni P.
Cardiovasc Revasc Med. 2018 Mar;19(2):215-220. doi: 10.1016/j.carrev.2017.09.002. Epub 2017 Sep 10.
Long-Term Follow-Up of Percutaneous Coronary Intervention With Paclitaxel-Eluting Balloon Catheter.
Sanchez-Perez I, Abellan-Huerta J, Jurado-Roman A, Lopez-Lluva MT, Pinilla-Echeverri N, Perez-Diaz P, Piqueras-Flores J, Lozano-Ruiz-Poveda F.
Angiology. 2021 Apr;72(4):364-370. doi: 10.1177/0003319720979246. Epub 2020 Dec 17.
Dexamethasone-eluting vascular stents.
Hämäläinen M, Nieminen R, Uurto I, Salenius JP, Kellomäki M, Mikkonen J, Kotsar A, Isotalo T, Teuvo Tammela LJ, Talja M, Moilanen E.
Basic Clin Pharmacol Toxicol. 2013 May;112(5):296-301. doi: 10.1111/bcpt.12056. Epub 2013 Mar 9.
Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients.
Megaly M, Ali A, Abraham B, Khalil C, Zordok M, Shaker M, Tawadros M, Hennawy BS, Elbadawi A, Omer M, Saad M.
Cardiovasc Revasc Med. 2020 Jan;21(1):78-85. doi: 10.1016/j.carrev.2019.03.001. Epub 2019 Mar 13.
Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
Liu L, Liu B, Ren J, Hui G, Qi C, Wang J.
BMC Cardiovasc Disord. 2018 Mar 2;18(1):46. doi: 10.1186/s12872-018-0771-y.
Drug-Coated Balloon Versus Drug-Eluting Stent in Primary Percutaneous Coronary Intervention: A Feasibility Study.
Gobić D, Tomulić V, Lulić D, Židan D, Brusich S, Jakljević T, Zaputović L.
Am J Med Sci. 2017 Dec;354(6):553-560. doi: 10.1016/j.amjms.2017.07.005. Epub 2017 Jul 19.
The Glider registry.
Secco GG, Rittger H, Hoffmann S, Richardt G, Abdel-Wahab M, Reinecke H, Lotan C, Werner G, Sievert H, Foin N, Di Mario C.
Catheter Cardiovasc Interv. 2017 Jan;89(1):E1-E6. doi: 10.1002/ccd.25040. Epub 2016 Oct 5.
Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions.
Tanaka A, Jabbour RJ, Mitomo S, Latib A, Colombo A.
JACC Cardiovasc Interv. 2017 Mar 27;10(6):539-547. doi: 10.1016/j.jcin.2016.12.285.
